Biotech IV Monitor

RCUS — Arcus Biosciences Inc.

$3.6B market cap · 2 upcoming readouts tracked

Clinical trial readout dates for Arcus Biosciences Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is April 2028.

Next readoutApril 2028in ~17 months
Upcoming readouts22 Phase 3
Market cap$3.6B
Cash & investments$845M~7 quarters at last loss rate
Recent 8-K filings4latest 2026-11-04

Recently completed

The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.

Phase 2 Domvanalimab
Non Small Cell Lung Cancer; Nonsquamous Non Small Cell Lung Cancer · NCT04736173
September 2026
Primary data collected
Phase 2 Domvanalimab
Gastrointestinal Tract Malignancies · NCT05329766
September 2026
Primary data collected
Phase 3 Domvanalimab
Advanced Upper Gastrointestinal Tract Adenocarcinoma · NCT05568095
August 2026
Primary data collected

Upcoming readouts

Phase 3 Casdatifan
Metastatic Clear Cell Renal Cell Carcinoma; Advanced Clear Cell Renal Cell Carcinoma · NCT07011719
April 2028
Recruiting
Phase 3 Quemliclustat
Metastatic Pancreatic Ductal Adenocarcinoma · NCT06608927
November 2030
Ongoing

Cash position

Arcus Biosciences Inc. reported $845M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-04). Its net loss for that quarter was $128M; at that rate the cash would last about 7 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.

Recent SEC filings

8-K Results of Operations — earnings, may carry pipeline updates2026-11-04
8-K Other Events — often topline trial data2026-10-23
8-K Results of Operations — earnings, may carry pipeline updates2026-10-21
8-K Other Events — often topline trial data2026-10-20

Companies working on similar indications

Discussion

No messages yet. If you follow RCUS, you can start the conversation.
Track RCUS in real time
See live implied volatility for RCUS and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on RCUS
Contact — questions or corrections about RCUS: dukeupt@gmail.com